Latest News - Verbund AG
Top Corporates Hub
Verbund AG
Pulnovo Medical Names Dr. Francis Duhay as Global Chief Medical Officer
25.08.2025 08:42
Pulnovo Medical, a global leader in mechanism-driven therapies for Pulmonary Hypertension (PH) and Heart Failure (HF), today announced the appointment of Francis Duhay, MD, MBA, FACS as Global Chief Medical Officer.
Global Non-invasive Brain Trauma Monitoring Device Market Size/Share Worth USD 32.19 Billion by 2034 at a 8.13% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)
21.08.2025 11:30
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Non-invasive Brain Trauma Monitoring Device Market size & share revenue was valued at approximately USD 14.7 Billion in 2024 and is expected to reach USD 14.98 Billion in 2025 and is expected to reach around USD 32.19 Billion by 2034, at a CAGR of 8.13% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Na
Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase
19.08.2025 20:15
IRVINE, Calif., August 19, 2025--Edwards Lifesciences (NYSE: EW) today announced that it has executed an accelerated share repurchase agreement ("ASR") to repurchase $500 million of Edwards’ common stock. With this transaction, Edwards has repurchased more than $800 million of shares in 2025.
FTC to block Edwards Lifesciences’ acquisition of JenaValve due to competitive concerns
15.08.2025 09:57
JenaValve is in the process of obtaining FDA approval for the first transcatheter aortic valve to address aortic regurgitation.
FTC files lawsuit to halt Edwards acquisition of JenaValve
07.08.2025 11:26
The FTC asserts that Edwards acquisition of JenaValve, given it now owns rival TAVR-AR firm JC Medical, will eliminate competition in the US artificial heart valve market.
Court Sides with Cardiovalve in Edwards patent spat
05.08.2025 12:00
Venus Medtech (Hangzhou) Inc. ("Venus Medtech", Stock Code: 02500.HK) recently announced a decisive legal victory for its wholly-owned subsidiary Cardiovalve Ltd. ("Cardiovalve") against Edwards Lifesciences Corporation and Edwards Lifesciences LLC. (collectively "Edwards"). The United States Court of Appeals for the Federal Circuit ("CAFC") has formally issued its mandate in Case 23-1515, affirming the Patent Trial and Appeal Board's ("PTAB") December 2022 ruling that upheld the validity of Car
Baron Health Care Fund Reacquired Edwards Lifesciences Corporation (EW) in Q2. Here’s Why
31.07.2025 13:01
Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund declined 5.06% (Institutional Shares) in the quarter, against a challenging backdrop for the broader Health Care sector, compared to a 6.19% decline for the Russell 3000 Health Care […]
Should You Add Edwards Lifesciences Stock to Your Portfolio Now?
18.07.2025 12:27
EW gains traction with surgical tech and TAVR growth, but macro pressures and FX headwinds weigh on margins.
Edwards Lifesciences to Host Earnings Conference Call on July 24, 2025
18.07.2025 11:05
IRVINE, Calif., July 18, 2025--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2025 after the market closes on Thursday July 24, 2025, and will host a conference call at 5:00 p.m. ET that day to discuss those results.
Earnings Preview: What To Expect From Edwards Lifesciences' Report
03.07.2025 10:12
Edwards Lifesciences is slated to unveil its second-quarter earnings this month, and analysts are projecting a double-digit decrease in earnings.
Edwards Lifesciences Corporation(NYSE: EW) dropped from Russell 1000 Growth Index
30.06.2025 09:07
Edwards Lifesciences Corporation dropped from Russell 1000 Growth Index...
Edwards Lifesciences Corporation(NYSE: EW) dropped from Russell 3000E Growth Index
30.06.2025 03:56
Edwards Lifesciences Corporation dropped from Russell 3000E Growth Index...
Edwards Lifesciences Corporation(NYSE: EW) dropped from Russell Top 200 Growth Index
30.06.2025 03:41
Edwards Lifesciences Corporation dropped from Russell Top 200 Growth Index...